Product Images Carbamazepine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Carbamazepine NDC 59746-791 by Jubilant Cadista Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Carbamazepine Extended-Release Tablets USP, 100 mg - NDC 59746-789-01 - 100's Bottle Label - carbamazepine er tablets usp 100mg 100s

Carbamazepine Extended-Release Tablets USP, 100 mg - NDC 59746-789-01 - 100's Bottle Label - carbamazepine er tablets usp 100mg 100s

This is a description for a medication called Carbamazepine in the form of coated tablets. Each tablet has a National Drug Code (NDC) of 59746-789-01 and is manufactured by Umedica Laboratories Pvt. Ltd. The packaging insert contains dosing information and the tablets are extended-release. Storage temperature is recommended between 20°C to 25°C (68°F to 77°F). The medication is distributed by Jubilant Cadista Pharmaceuticals Inc. and comes in a container with instructions to keep the tablets dry, dispense in a tight container, and away from children.*

Carbamazepine Extended-Release Tablets USP, 200 mg - NDC 59746-790-01 - 100's Bottle Label - carbamazepine er tablets usp 200mg 100s

Carbamazepine Extended-Release Tablets USP, 200 mg - NDC 59746-790-01 - 100's Bottle Label - carbamazepine er tablets usp 200mg 100s

This is a description of Carbamazepine USP extended-release tablets manufactured by Umedica Laboratories Pvt. Ltd in India and distributed by Jubilant Cadista Pharmaceuticals Inc. in the USA. The tablets contain 200 mg of carbamazepine and are to be swallowed whole, not crushed or chewed. Dosage information is available in the package insert, and the tablets should be kept in a tight container protected from moisture. They should be stored between 20°C and 25°C (68°F to 77°F) with excursions permitted between 15°C and 30°C (59°F and 86°F) and kept out of reach of children. The NDC number is 59746-790-01.*

Carbamazepine Extended-Release Tablets USP, 400 mg- NDC 59746-791-01 - 100's Bottle Label - carbamazepine er tablets usp 400mg 100s

Carbamazepine Extended-Release Tablets USP, 400 mg- NDC 59746-791-01 - 100's Bottle Label - carbamazepine er tablets usp 400mg 100s

Each tablet of Cadista's Carbamazepine Extended-Release contains 400 mg of Carbamazepine USP. It is important to swallow the tablet whole and never crush or chew it. Dosage details can be found in the package insert. This medication must be stored between 20°C to 25°C, with excursions permitted between 15°C and 30°C. Protect it from moisture and keep it out of the reach of children. It should be dispensed in a tight container along with the Medication Guide attached or provided separately. The product is manufactured by Umedica Laboratories Put. Ltd. in Vapi, India, and distributed by Jubilant Cadista Pharmaceuticals Inc. in Salisbury, USA.*

image description - carbamazepine structure

image description - carbamazepine structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.